SWP
ABBV icon

Sagespring Wealth Partners’s AbbVie ABBV Stock Holding History

Sagespring Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.82M Buy
39,038
+1,172
+3% +$252K 0.15% 81
2026
Q1 		$8.24M Sell
37,866
-695
-2% -$154K 0.15% 87
2025
Q4 		$8.81M Buy
38,561
+510
+1% +$116K 0.16% 77
2025
Q3 		$8.81M Buy
38,051
+4,192
+12% +$854K 0.17% 70
2025
Q2 		$6.28M Buy
33,859
+10,105
+43% +$1.88M 0.14% 88
2025
Q1 		$4.98M Buy
23,754
+4,138
+21% +$804K 0.13% 88
2024
Q4 		$3.49M Buy
+19,616
New +$3.61M 0.09% 101

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sagespring Wealth Partners's ABBV Position: Q2 2026 in Review

Sagespring Wealth Partners increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $252K and bringing the position to 39,038 shares worth $9.82M. The position accounts for 0.15% of the portfolio, ranked #81.

Sagespring Wealth Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sagespring Wealth Partners held 39,038 shares of AbbVie worth $9.82M as of Q2 2026.
  • Sagespring Wealth Partners bought 1,172 AbbVie shares in Q2 2026, an estimated $252K.
  • AbbVie made up 0.15% of Sagespring Wealth Partners's portfolio in Q2 2026, its #81 holding.
  • Sagespring Wealth Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.